chr3-132559005-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_032169.5(ACAD11):c.2309G>A(p.Arg770Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000762 in 1,613,646 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_032169.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACAD11 | NM_032169.5 | c.2309G>A | p.Arg770Gln | missense_variant | 20/20 | ENST00000264990.11 | |
NPHP3-ACAD11 | NR_037804.1 | n.6921G>A | non_coding_transcript_exon_variant | 45/45 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACAD11 | ENST00000264990.11 | c.2309G>A | p.Arg770Gln | missense_variant | 20/20 | 1 | NM_032169.5 | P1 | |
ACAD11 | ENST00000485198.5 | c.*790G>A | 3_prime_UTR_variant, NMD_transcript_variant | 18/18 | 1 | ||||
ACAD11 | ENST00000469042.5 | n.3095G>A | non_coding_transcript_exon_variant | 18/18 | 2 | ||||
ACAD11 | ENST00000496418.5 | n.2817G>A | non_coding_transcript_exon_variant | 19/19 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000148 AC: 37AN: 250846Hom.: 1 AF XY: 0.000133 AC XY: 18AN XY: 135568
GnomAD4 exome AF: 0.0000725 AC: 106AN: 1461410Hom.: 3 Cov.: 30 AF XY: 0.0000702 AC XY: 51AN XY: 727008
GnomAD4 genome AF: 0.000112 AC: 17AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74430
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 02, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at